Advanced Biomed (ADVB) Depreciation & Amortization (CF) (2023 - 2026)
Advanced Biomed (ADVB) posted Depreciation & Amortization (CF) of $9326.0 for Q1 2026, up 172.54% sequentially from -$12857.0 in Q4 2025, and down 58.56% YoY from $22507.0 in Q1 2025.
Advanced Biomed (ADVB) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Advanced Biomed (ADVB) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $9326.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 58.56% year-over-year to $9326.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $320326.0 (up 44.37% YoY) and the FY2025 annual result came in at $343830.0, down 13.96% from the prior year.
- Depreciation & Amortization (CF) grew to $9326.0 in Q1 2026 per ADVB's latest filing, from -$12857.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $275865.0 in Q2 2025, with the low at -$56760.0 in Q4 2024.
- Average Depreciation & Amortization (CF) over 4 years is $68311.7, with a median of $52945.5 recorded in 2023.
- Year-over-year, Depreciation & Amortization (CF) sank 198.03% in 2024 and soared 79.24% in 2025.
- Advanced Biomed's Depreciation & Amortization (CF) stood at $57899.0 in 2023, then slumped by 198.03% to -$56760.0 in 2024, then soared by 77.35% to -$12857.0 in 2025, then soared by 172.54% to $9326.0 in 2026.
- Business Quant data shows ADVB's Depreciation & Amortization (CF) at $9326.0 in Q1 2026, -$12857.0 in Q4 2025, and $47992.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 36.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 306.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 193.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 37.68 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 14.52 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 67.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 288.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 51.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 13.16 Mn |
| 10 | Advanced Biomed | 6.22 Mn | 6.22 Mn | - | 9,326.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,326.00 |
| Mar 31, 2026 | 9,326.00 |
| Dec 31, 2025 | -12,857.00 |
| Dec 31, 2025 | -12,857.00 |
| Sep 30, 2025 | 47,992.00 |
| Sep 30, 2025 | 47,992.00 |
| Jun 30, 2025 | 275,865.00 |
| Jun 30, 2025 | 275,865.00 |
| Mar 31, 2025 | 22,507.00 |
| Mar 31, 2025 | 22,507.00 |
| Dec 31, 2024 | -56,760.00 |
| Dec 31, 2024 | -56,760.00 |
| Sep 30, 2024 | 102,218.00 |
| Sep 30, 2024 | 102,218.00 |
| Jun 30, 2024 | 153,911.00 |
| Jun 30, 2024 | 153,911.00 |
| Mar 31, 2024 | 83,016.00 |
| Mar 31, 2024 | 83,016.00 |
| Dec 31, 2023 | 57,899.00 |
| Dec 31, 2023 | 57,899.00 |